Bextra Withdrawal Could Be Just the Beginning for Pfizer
The pharmaceutical industry is a tremendously profitable one, as anyone who reads the business pages of their newspaper can see. Although it can take years to develop a new drug and bring it to market, the profits obtained from a breakthrough drug can be staggering. Last year Merck sold about $2.5 billion worth of Vioxx, and Pfizer sold about $1.3 billion worth of Bextra. The profits are huge, but so are the losses if a problem should develop with a pharmaceutical product. Pfizer voluntarily withdrew the popular anti-inflammatory drug Bextra from the market last month, and their stock has suffered from both the loss of sales and the potential for a large number of product liability lawsuits. Pfizer may have to endure a double whammy this year as the FDA announced that they are investigating reports that the impotence drug Viagra may be linked to cases of blindness in male users. Cialis and Levitra were also mentioned in the report, although most of the cases involved the use of Viagra.
The FDA reports shouldn't cause alarm; the agency says that it is investigating fewer than 50 incidents of blindness in patients who use a drug that has been used by more than twenty million people since its introduction seven years ago. The FDA investigation says less about the likelihood of blindness in patients than it does about the agency's own concerns about its reputation. The FDA rightly insists upon rigorous testing of drugs before they reach the market in the name of public safety. But that coin has two sides, and there are those who say that the agency is too quick to approve potentially dangerous drugs and others who say that the agency's testing isn't thorough enough. Adding fuel to the fire are the recent memos obtained from Merck employees that suggest that the company was aggressively marketing Vioxx even though their sales staff knew the drug was potentially dangerous.
There may be no link between Viagra and blindness at all, as the form of sudden blindness alleged to have been caused by Viagra use is common to the sorts of patients who have erectile disfunction. The FDA is just being cautious, as they should be. Further tests will determine if there is an actual link. The party likely to suffer immediately is Pfizer, as stockholders, already concerned about Bextra lawsuits, drove the stock price lower immediately upon the release of the Viagra news. Sales will probably decrease, too, as patients who are now accustomed to reading about drugs being withdrawn from the market may shy away from the product until further tests are done. That could present a huge income for Pfizer, as they currently sell about $2 billion worth of Viagra each year. The drug business is a profitable one, but like any business, comes with risks. This year, it would seem that Pfizer is getting a double dose of bad medicine.
©Copyright 2005 by Retro Marketing. Charles Essmeier is the owner of Retro Marketing, a firm devoted to informational Websites, including Bextra-Info.net, a site devoted to the withdrawn drug Bextra and StructuredSettlementHelp.com, a site devoted to structured settlements.
Latest News
$700 billion? Don’t think bailout, think money spent on medicine Bizjournals.com, NC - ... drug companies and doctors swayed by them, said the author of “Overdo$ed America: The Broken Promise of American Medicine,” published in 2004. ... |
National Academy of Sports Medicine Launches New Course ... MarketWatch - CALABASAS, CA, Nov 21, 2008 (MARKET WIRE via COMTEX) -- The National Academy of Sports Medicine (NASM; www.nasm.org), a leader in fitness training ... |
Physical therapy a new field of pet medicine Aurora Beacon News, IL - By DENISE LINKE Special to The Beacon News NORTH AURORA -- Oreo was one of the friskiest, most energetic Boston terriers in Oswego, said owner Mike Donzelli ... |
 KGET 17 | Foes of stem cell research now face tough battle The Associated Press - But Sean Tipton, director of public affairs at the American Society for Reproductive Medicine, took aim at those arguments. "It's a little disingenuous for ... Obama may fund stem cell research |
Auto bailout: The best medicine? Florida Times-Union, FL - By The Times-Union They already received $25 billion in low interest government loans intended to help them transition to a new generation of fuel efficient ... The wrong medicine Motor city seeks answers Detroit bailout? No way! |
Naturopathic doctor popular among Hispanics Newsday, NY - The medicines she gave me helped calm the pain a lot." Robinson, one of many doctors in the small but growing field of naturopathic medicine, ... |
 TheMedGuru | Three Employees Fired After Patient Chokes on Medicine, Dies FOXNews - GOLDSBORO, NC — North Carolina officials have fired three employees and disciplined others in the death of a patient who was neglected for more than 22 ... Firings a good first step in neglect case |
Medicine Hat finishes busy stretch with a 4-1 victory over the ... The Canadian Press, Alta. - MEDICINE HAT, Alta. — The Medicine Hat Tigers certainly earned some time off. On Saturday, the Western Hockey League club closed out one of the busiest ... |
Healthcare for Avatars? Medicine in the Metaverse E-Commerce Times - By Laura Bruck Some industries have been more receptive than others to the idea of conducting business in virtual worlds such as Second Life. ... |
Exploring: medicine the world of Asbury Park Press, NJ - The club, which offers education and activities for teenagers considering a career in medicine, is a program of Learning for Life, a Boy Scouts of America ... |
Resources
-
Sorry Currently Unavailable